Nano Anti-Cancer Drugs: Pros and Cons and Future Perspectives

Author(s): I. Ali

Journal Name: Current Cancer Drug Targets

Volume 11 , Issue 2 , 2011

Become EABM
Become Reviewer


For the last one decade, scientists are working at developing nano anti-cancer drugs with the claim of ideal ones due to their targeted chemotherapic nature. These drugs have many beneficial properties such as targeted drug delivery and gene therapy modalities with minimum side effects. This article describes pros and cons and future perspectives of nano anti-cancer drugs. Efforts have been made to address the importance, special features, toxicities (general, blood identities, immune system and environmental) and future perspectives of nano anti-cancer drugs. It was concluded that nano anti-cancer drugs may be magic bullet drugs for cancer treatments leading to a bright future of the whole world.

Keywords: Nano anti-cancer drugs, pros and cons, toxicities, special features, future perspectives, immune system, micelles, dendrimers, micro-capsules, multidrug resistance, chemotherapy, paclitaxel, tumor, dendritic cells, neutropenia, thrombocytopenia, serum transaminase levels, gadolinium, fibrosis, synergistic efficacy, Deoxyribo nucleic acid, Interferon-, Inter Leukin-6, Inter Leukin-12, Multi drug resistance, Poly ethylene glycol, Red blood corpuscles, Small interfering ribo nucleic acids, Tumor necrosis factor, White blood corpuscles

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [131 - 134]
Pages: 4
DOI: 10.2174/156800911794328457
Price: $65

Article Metrics

PDF: 16